Literature DB >> 3913948

Lymph node modification in patients with the acquired immunodeficiency syndrome (AIDS) or with AIDS related complex (ARC). A histological, immuno-histopathological and ultrastructural study of 45 cases.

J Diebold, C Marche, J Audouin, J P Aubert, A Le Tourneau, C Bouton, M Reynes, J Wizniak, F Capron, V Tricottet.   

Abstract

The authors present the results of a histopathological study on the lymph-nodes taken from 45 subjects suffering from either an AIDS or from a chronic adenopathy corresponding to the definition of AIDS related complex (ARC). The various aspects observed were classed as type I to type IV. The lymph-node modifications observed in the 29 patients with an ARC could be divided into three principle groups: an extensive follicular hyperplasia associated with other elementary lesions or type IA (25 lymph-nodes from 23 patients); changes resembling a multicentric Castleman syndrome or type IB (1 case); angioimmunoblastic-like (AIL) lesions or type II (2 cases) and an association of lesions of type II (7 lymph-nodes from 6 patients). During AIDS, the adenopathy usually disappears, and the small lymph-nodes removed, especially on autopsy, show an extensive lymphoid depletion (type III) with systematic sclerosis (15 lymph-nodes from 14 patients). When adenopathy persists, it is due to infections complications (tuberculosis, cryptococcosis, avian mycobacteriosis and Whipple's disease like lesions). Of the 10 patients in whom a Kaposi's sarcoma was observed, only 6 showed lymph-node involvement, or type IV. The different histopathological lesions seem to appear according to an evolving succession, proven by certain association of lesions and by successive biopsies. In our series, 17% of subjects with an ARC evolved to AIDS. Lymph-node biopsy allows a possible ARC to be implicated on the association of the following simple lesions: follicular hyperplasia with partial or total destruction of the perifollicular lymphocytic cisterna, infiltration of the germinative centres by streams of small lymphocytes, evolving to an aspect of a "burst" germinative centre and various sinusal reactions with, in particular, the presence of neutrophilic polynuclear cells. The biopsy also allows the forms with bad prognosis to be recognized: those with AIL-like aspect or multicentric Castleman-like syndrome, which seems to represent a particular evolutive form. Finally, it also detects, in certain cases, the localization of a Kaposi syndrome, signalling the passage to AIDS. The immunopathological studies present a double interest. Firstly, they offer arguments in favour of the diagnosis: increase in the number of T8 lymphocytes in the germinative centres with the formation of small clusters and disruption of the network of dendritic reticular cells, and the inversion of the T4/T8 ratio in the extra-follicular cortical regions, by either a decrease in T4 lymphocytes or by an increase in T8 lymphocytes.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3913948     DOI: 10.1016/S0344-0338(85)80037-6

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

1.  Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection.

Authors:  N Tedla; P Palladinetti; M Kelly; R K Kumar; N DiGirolamo; U Chattophadhay; B Cooke; P Truskett; J Dwyer; D Wakefield; A Lloyd
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

2.  Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV).

Authors:  L V Chalifoux; D J Ringler; N W King; P K Sehgal; R C Desrosiers; M D Daniel; N L Letvin
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

3.  Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo.

Authors:  M Kitagawa; A A Lackner; D J Martfeld; M B Gardner; S Dandekar
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

4.  Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy.

Authors:  D J Ringler; M S Wyand; D G Walsh; J J MacKey; L V Chalifoux; M Popovic; A A Minassian; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  Cellular localization of simian immunodeficiency virus in lymphoid tissues. II. In situ hybridization.

Authors:  M S Wyand; D J Ringler; Y M Naidu; M Mattmuller; L V Chalifoux; P K Sehgal; M D Daniel; R C Desrosiers; N W King
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

6.  Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells.

Authors:  L Chakrabarti; P Isola; M C Cumont; M A Claessens-Maire; M Hurtrel; L Montagnier; B Hurtrel
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections.

Authors:  J M Ward; T J O'Leary; G B Baskin; R Benveniste; C A Harris; P L Nara; R H Rhodes
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

8.  Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients.

Authors:  K Tenner-Racz; P Racz; C Thomé; C G Meyer; P J Anderson; S F Schlossman; N L Letvin
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

9.  Human immunodeficiency virus-infected multinucleated histiocytes in oropharyngeal lymphoid tissues from two asymptomatic patients.

Authors:  A Rinfret; H Latendresse; R Lefebvre; G St-Louis; P Jolicoeur; L Lamarre
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

10.  Pediatric Cryptococcal Lymphadenitis in the Absence of AIDS: Case Report and Literature Review.

Authors:  Fengchang Bao; Hongna Tan; Wei Liu; Yange Li; Huixia Li
Journal:  Case Rep Pediatr       Date:  2013-06-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.